肺纤维化细胞因子参与机制及中药治疗研究进展  

Cytokine Mechanism Involved in Pulmonary Fibrosis and Research Progress of Its Treatment with Traditional Chinese Medicine

作　　者：庄文越[1] 马周义 赵娜 陈建光[2] 

机构地区：[1]北华大学医学检验学院,吉林吉林132013 [2]北华大学药学院,吉林吉林132013

出　　处：《北华大学学报（自然科学版）》2017年第5期615-619,共5页Journal of Beihua University（Natural Science）

基　　金：吉林省科技发展计划项目(20150312041ZG;20160101234JC);吉林省教育厅科学技术研究项目(201673);吉林省卫生计生委青年科研项目(2014Q039);北华大学大学生校级创新创业训练计划项目(201300189)

摘　　要：肺纤维化是一种难治性、高致病率且病因尚未明确的慢性弥漫性肺间质炎症性疾病.目前,肺纤维化发病机制尚不明确,越来越多的研究发现:其是由多种细胞因子通过多条信号通路进行调控的过程.因肺纤维化缺乏有效的治疗手段,故其死亡率也在逐年增高,中药治疗肺纤维化已成为医学相关领域的研究热点.本文就近年来参与肺纤维化发病机制的细胞因子以及中药治疗研究进行综述.Pulmonary fibrosis is a kind of chronic diffuse interstitial lung inflammatory disease that is intractable, with a high incidence of disease. At present,the pathogenesis of pulmonary fibrosis is not clear,and more and more studies have found that it is a process of regulation by a variety of cytokines through a number of signaling pathways. Due to the lack of effective treatment for pulmonary fibrosis, the mortality rate is increasing year by year. The research of treatment of pulmonary fibrosis with traditional Chinese medicine has become a hot spot. Recent studies on the pathogenesis of pulmonary fibrosis about cytokines and the treatment with traditional Chinese medicine are reviewed.

关 键 词：肺纤维化 发病机制 细胞因子 中药治疗 

分 类 号：R256.1[医药卫生—中医内科学]